Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $720,822 - $1.34 Million
-5,700 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $293,566 - $479,063
-1,300 Reduced 18.57%
5,700 $1.45 Million
Q2 2021

Oct 26, 2021

BUY
$129.91 - $234.98 $909,370 - $1.64 Million
7,000 New
7,000 $1.65 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Quantedge Capital Pte LTD Portfolio

Follow Quantedge Capital Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quantedge Capital Pte LTD with notifications on news.